Aimia (AIM) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
24 Mar, 2026Executive summary
Achieved annual guidance and maintained momentum into 2026, highlighted by a definitive agreement to divest the specialty chemicals core holding, Bozzetto, accelerating transition to a permanent capital vehicle.
Progressed on a three-step strategy: reducing Holdco costs, narrowing share price discount, and deploying capital effectively.
Ended 2025 with higher cash, lower holding company costs, and over 5.9 million common shares repurchased.
Near-term priorities include closing the Bozzetto sale, investing in undervalued companies, monetizing non-core investments, and renewing the NCIB.
Financial highlights
Q4 2025 consolidated revenue was $118.5 million, down 6.8% year-over-year, impacted by lower volumes, pricing pressures, and macroeconomic/geopolitical factors.
Gross profit for Q4 was $31.0 million, nearly flat year-over-year; gross margin improved to 26.2%.
Adjusted EBITDA for Q4 2025 was $16.7 million, slightly below prior year; full-year adjusted EBITDA was $76.4 million, up 48.9%.
Net loss for Q4 2025 was $9.9 million, mainly due to a non-cash goodwill impairment charge at Cortland; full-year net loss was $12.6 million, a 76.4% improvement.
Cash and equivalents at year-end were $109.2 million, up from $106 million at Q3 end.
Outlook and guidance
Core holdings generated $85.6 million in adjusted EBITDA, in line with targets; Holdco costs were $7.7 million, below the $9 million target.
No guidance for 2026 due to the planned sale of Bozzetto.
Focus remains on closing the Bozzetto transaction in Q2 2026, redeeming senior notes, and investing in undervalued companies.
Latest events from Aimia
- Sale yields CAD 265–271M for debt reduction, new investments, and tax loss utilization.AIM
M&A announcement27 Feb 2026 - Q2 2024 delivered higher adjusted EBITDA, strong liquidity, and active capital return initiatives.AIM
Q2 20241 Feb 2026 - Q3 2024 saw double-digit revenue and EBITDA growth, strategic alignment, and strong liquidity.AIM
Q3 202415 Jan 2026 - Strong Q4 and FY2024 growth, capital structure gains, and positive 2025 EBITDA outlook.AIM
Q4 202425 Dec 2025 - Q1 revenue and EBITDA surged on cost cuts, core growth, and a $53.8M issuer bid gain.AIM
Q1 202526 Nov 2025 - Revenue and adjusted EBITDA rose in Q2 2025, with cost targets lowered amid tariff headwinds.AIM
Q2 202523 Nov 2025 - Returned to profit with strong EBITDA, cash flow, and 8.9% share reduction.AIM
Q3 202512 Nov 2025